The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[4-(4-Chlorophenoxy)phenyl]-3-[(1S)-1-(1,6-dimethylbenzimidazol-2-yl)-2-[1-(2-methylpropanoyl)-4-piperidyl]ethyl]imidazolidine-2,4-dione ID: ALA4556659
PubChem CID: 155557101
Max Phase: Preclinical
Molecular Formula: C35H38ClN5O4
Molecular Weight: 628.17
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2nc([C@H](CC3CCN(C(=O)C(C)C)CC3)N3C(=O)CN(c4ccc(Oc5ccc(Cl)cc5)cc4)C3=O)n(C)c2c1
Standard InChI: InChI=1S/C35H38ClN5O4/c1-22(2)34(43)39-17-15-24(16-18-39)20-31(33-37-29-14-5-23(3)19-30(29)38(33)4)41-32(42)21-40(35(41)44)26-8-12-28(13-9-26)45-27-10-6-25(36)7-11-27/h5-14,19,22,24,31H,15-18,20-21H2,1-4H3/t31-/m0/s1
Standard InChI Key: IJWQFQTVUNUINJ-HKBQPEDESA-N
Molfile:
RDKit 2D
45 50 0 0 0 0 0 0 0 0999 V2000
30.4534 -22.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4523 -23.0364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1603 -23.4453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8700 -23.0359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8671 -22.2132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1585 -21.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5783 -23.4434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6655 -24.2535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4652 -24.4222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8727 -23.7138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3248 -23.1075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0594 -24.8016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.6852 -23.6270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.6741 -25.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4629 -25.4224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7567 -26.1843 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.1018 -24.9080 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7862 -25.3545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5710 -26.1394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1426 -26.7163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9295 -26.5093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1417 -25.7204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5686 -25.1470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0611 -24.0918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9312 -25.5093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0949 -25.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3046 -26.5754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7220 -27.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9289 -27.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7169 -28.1539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2982 -27.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0913 -26.7849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9236 -28.9445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3423 -29.5188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7117 -29.1609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9184 -29.9515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2930 -28.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7456 -21.8084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0380 -22.2172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3303 -21.8070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6232 -22.2151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6229 -23.0332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3357 -23.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0399 -23.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9159 -23.4429 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 7 1 0
8 12 2 0
10 13 2 0
9 14 1 0
14 15 1 0
15 16 2 0
16 19 1 0
18 17 1 0
17 15 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
17 24 1 0
22 25 1 0
14 26 1 6
26 27 1 0
27 28 1 0
27 32 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
30 33 1 0
33 34 2 0
33 35 1 0
35 36 1 0
35 37 1 0
1 38 1 0
38 39 1 0
39 40 2 0
40 41 1 0
41 42 2 0
42 43 1 0
43 44 2 0
44 39 1 0
42 45 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 628.17Molecular Weight (Monoisotopic): 627.2612AlogP: 7.12#Rotatable Bonds: 8Polar Surface Area: 87.98Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.33CX Basic pKa: 4.79CX LogP: 6.12CX LogD: 6.12Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.19Np Likeness Score: -1.19
References 1. Teno N, Yamashita Y, Masuda A, Iguchi Y, Oda K, Fujimori K, Hiramoto T, Nishimaki-Mogami T, Une M, Gohda K.. (2019) Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonists., 27 (11): [PMID:31029550 ] [10.1016/j.bmc.2019.04.029 ]